TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A November 28, 1980
TCL Archive NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines. September 19, 2008